In vitro evaluation of a biologic graft surface. Effect of treatment with conventional and low molecular weight (LMW) heparin
- 1 September 1984
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 35 (6) , 653-663
- https://doi.org/10.1016/0049-3848(84)90268-8
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Decreased Acute Thrombogenicity of Human Umbilical Veins after Heparin and Alcohol TreatmentEuropean Surgical Research, 1983
- A New Non-Thrombogenic Surface Prepared by Selective Covalent Binding of Heparin Via a Modified Reducing Terminal ResidueBiomaterials, Medical Devices, and Artificial Organs, 1983
- Comparison between commercial heparin, low molecular weight heparin and pentosan polysulfate on hemostasis and platelets in vivoThrombosis Research, 1982
- Uptake and inhibition of thrombin by the vascular wallThrombosis Research, 1982
- Uptake and inactivation of thrombin by the fresh, glutardialdehyde or heparin treated human umbilical cord vein endotheliumThrombosis Research, 1981
- Clearance of Thrombin from Circulation in Rabbits by High-affinity Binding Sites on EndotheliumJournal of Clinical Investigation, 1980
- Inhibition of thrombin by antithrombin III in the presence of certain glycosaminoglycans found in the mammalian aortaThrombosis Research, 1978
- Occurrence of heparin or its related acidic glucosaminoglycan in human aortic tissueCellular and Molecular Life Sciences, 1973
- Sulfated mucopolysaccharide synthesis and secretion in endothelial cell culturesExperimental Cell Research, 1973
- Anticoagulant Activity of Human Arterial MucopolysaccharidesNature, 1959